Double-syringe vs Single-syringe Technique of Adenosine for Termination of Regular Narrow Complex Tachycardia

Launched by KHON KAEN UNIVERSITY · Aug 21, 2021

Keywords

ClinConnect Summary

This clinical trial is studying two different ways to give a medication called adenosine to patients experiencing a specific type of fast heartbeat known as supraventricular tachycardia. Adenosine can help slow down the heart and is usually given using a method called the double syringe technique, which requires more equipment and staff. However, some earlier studies suggest that a simpler method using just one syringe might work just as well. The goal of this trial is to compare these two methods to see if the single syringe approach is just as effective.

To participate in this trial, individuals need to be between 18 and 80 years old and have a fast heartbeat that has not improved with other techniques. They must also be able to feel their pulse. However, people with certain conditions, like asthma attacks, pregnancy, or serious heart problems, cannot join. If someone decides to participate, they will help researchers understand which method of giving adenosine is better, which could make treatment easier and more efficient in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age between 18-80 years old
• • EKG shows regular rhythm, narrow QRS complex tachyarrhythmias (QRS complex \<0.12 msec, and rate \>150 beats per minute; bpm)
• • Pulse can be palpated
• • The tachycardia is not terminated by a vagal maneuver.
• Exclusion Criteria:
• • Acute asthmatic attack
• • Pregnant or tendency to be pregnant
• • Acute heart failure
• • Acute chest pain
• • Alteration of consciousness
• • Hypotension
• • Presenting of signs of hypoperfusion